• As the Real World Evidence expert, support drug development strategy throughout the life cycle for innovative products by conducting research in collaboration with HEOR, Medical Affairs, Clinical Development, Epidemiology, Value Access and Pricing, Commercial and Market Access teams.
• Generate robust real world evidence through observational research and health economic modeling for peer-reviewed publications, presentation at scientific congresses, payer/provider communication, value dossiers, value based contracting, Market Access tools and HTA submissions to support development of new assets and demonstrate value of marketed products.
• Conceptualize and execute HEOR (Economic burden of illness, comparative effectiveness studies, cost benefit analysis, healthcare utilization and forecasting) and Epidemiology research (incidence, prevalence, natural disease progression, treatment patterns, signal detection, safety surveillance, etc) in alignment with medical and commercial strategy.
• Responsible for leading research studies through development of study protocols, statistical analysis plans (SAP), programming specifications, statistical analyses and modeling, literature reviews, interpretation and presentation of analytical findings to leadership team and stakeholders.
• Responsible for data landscaping and evaluation of data sources such as healthcare claims, integrated EMR, registries, independent research groups etc. for acquisition and collaboration.
• Develop comprehensive real world evidence strategy plan based on HEOR, Epidemiology, Commercial and Medical Affairs strategy. Effectively maintain and execute a dynamic book of work with robust timelines.
• Collaborate with third party vendors, academic researchers, KOLs and external consultants to manage HEOR and epidemiology projects to ensure timely completion of high quality research.
• Mentoring, managing work assignments and project deliverables for assigned analysts.

• Led biostatistics activities such as development of Statistical Analysis Plans (SAP), table shells, programming specifications for analysis data sets, tables, listings and figures, data analysis and statistical reports.
• Developed methodological strategies and research study design for phase III, IV and Late phase studies, observational registries, comparative effectiveness, and HEOR studies.
• Provided statistical oversight for new study proposals (RFP), study protocol development, clinical study report writing and manuscripts while working in a cross-functional environment with Data Managers, Epidemiologists, Medical team and Business Development team.
• Collaborated with pharmaceutical and academic clients throughout the study period to ensure accurate delivery of final study results.
• Developed study timelines and managed multiple teams of programmers to complete study deliverables.
• Established scope of work, budget and timelines for completion of research studies. Managed project budget and resource requirements; provided revenue and resource forecasts for studies.
• Worked with the data management team to develop electronic Case Report Forms (CRF), database design, identification of critical data elements, CRF completion guidelines and clinical data reviews.
• Worked in a wide range of therapeutic areas: Oncology, Infectious diseases, Cardiovascular diseases, Endocrinology, Psychiatric diseases, Hematology, Ophthalmology and Viral diseases.

• Developed and supported various clinical intervention programs such as Medication Adherence, High Risk Medications, Diabetes Therapy Management, Interventions to drive CMS stars rating and HEDIS measures.
• Developed study designs and performed statistical analyses to quantify health outcomes of clinical intervention programs based on randomized control studies.
• Analyzed Pharmacy and medical claims using SAS, Enterprise Miner and SQL programs.
• Conducted retrospective drug utilization reviews and developed predictive models.
• Selected and assigned study population using various stratification methodologies to maintain the homogeneity of studies.
• Conducted SAS programming, trends saving modeling and analysis, created and maintained monthly tables, reports and dashboards, conducted Ad-Hoc Analysis and peer reviews, created and delivered presentations of analytical findings.
• Provided critical utilization data for drug formulary development.
• Worked as a part of Pharmacy Benefit Manger (PBM) team.

Conducted Health economics, systematic review and meta-analysis research; assisted in grant writing; developed surveys and performed data analysis; developed presentation and project reports and conducted extensive literature reviews.